Concepedia

Anjie Zhu

AZ

Statistics

Publications

7

Citations

198

H-Index

7

Active since

2016

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Peking University Cancer Hospital

Peking University

Capital Medical University

Anjie Zhu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, medicine, and pharmacology.

Publications per year

2016–2021

7

Publications

7

SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer

Anjie Zhu, Peng Yuan, Feng Du et al. · Oncotarget · 2016 · 63 citations · Full text

, , +11

Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer

Feng Du, Wenmiao Wang, Yongsheng Wang et al. · Breast Cancer Research and Treatment · 2020 · 36 citations

, , +14

Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study

Xue Wang, Anjie Zhu, Jiayu Wang et al. · Therapeutic Advances in Medical Oncology · 2020 · 27 citations · Full text

, , +16

Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study

Anjie Zhu, Peng Yuan, Jiayu Wang et al. · Oncology Letters · 2019 · 21 citations · Full text

, , +17

RETRACTED: A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer

Nanlin Hu, Anjie Zhu, Yiran Si et al. · Frontiers in Oncology · 2021 · 19 citations · Full text

, , +14

1–5 of 7